Balance Sheet

Current Liabilities	90.8m
Accounts Payable	10.3m
Accrued Liabilities	39m
Other Current Liabilities	41.6m
Non-Current Liabilities	230.5m
Long-Term Debt	223.9m
Other Non-Current Liabilities	6.6m

Currency: USD

	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022
Assets
Cash & Cash Equivalents	13	20	33	44	70	43	70	58	85	51
Cash Equivalents	13	20	33	44	70	43	70	58	85	51
Short-Term Investments	132	220	595	646	345	393	583	412	335	435
Total Receivables	1	3	4	12	19	26	38	42	28	27
Accounts Receivables	0	0	0	9	17	26	38	42	28	27
Other Receivables	0	0	0	3	2	0	0	0	0	0
Other Current Assets	1	4	10	6	15	21	31	35	60	28
Total Current Assets	148	246	642	708	448	482	721	546	508	540
PP&E Net	2	6	10	11	16	10	18	19	7	6
PP&E Gross	2	6	10	11	16	10	18	19	7	6
Accumulated Depreciation	0	1	2	5	9	12	14	17	18	4
Other Long-Term Assets	1	3	4	20	20	16	15	16	12	7
Total Assets	150 N/A	254 +69%	656 +158%	739 +13%	484 -34%	509 +5%	755 +48%	581 -23%	527 -9%	554 +5%
Liabilities
Accounts Payable	3	3	4	7	7	12	19	25	18	14
Accrued Liabilities	2	4	11	27	35	28	63	83	41	43
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	0	0	0	0	0	0	0	0	0	110
Other Current Liabilities	4	8	32	45	63	75	81	71	109	64
Total Current Liabilities	9	15	47	79	104	114	162	179	168	230
Long-Term Debt	0	0	0	341	356	371	532	561	540	223
Other Liabilities	59	8	6	5	8	5	9	8	3	7
Total Liabilities	68 N/A	23 -66%	54 +130%	424 +692%	468 +10%	490 +5%	703 +44%	747 +6%	711 -5%	461 -35%
Equity
Common Stock	0	0	0	0	0	0	0	0	0	0
Retained Earnings	186	469	696	1 109	1 470	1 779	2 124	2 398	2 490	2 137
Additional Paid In Capital	268	700	1 300	1 426	1 487	1 800	2 176	2 234	2 309	2 238
Other Equity	0	0	2	3	1	2	1	3	3	8
Total Equity	82 N/A	231 +180%	602 +161%	315 -48%	16 -95%	19 +16%	52 +170%	167 N/A	184 -10%	93 N/A
Total Liabilities & Equity	150 N/A	254 +69%	656 +158%	739 +13%	484 -34%	509 +5%	755 +48%	581 -23%	527 -9%	554 +5%
Shares Outstanding
Common Shares Outstanding	19	21	24	25	25	30	33	33	30	42

Intercept Pharmaceuticals Inc
NASDAQ:ICPT